261 related articles for article (PubMed ID: 22000257)
1. [The results of combined treatment patients with olfactory neuroblastoma in material of Cancer Center in Warsaw].
Jarząbski A; Kiprian D; Szutkowski Z; Kawecki A; Michalski W
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):93-7. PubMed ID: 22000257
[TBL] [Abstract][Full Text] [Related]
2. [Olfactory neuroblastoma: own experiences].
Jarzabski A; Kawecki A; Jagielska B
Otolaryngol Pol; 2000; 54 Suppl 31():94-7. PubMed ID: 10974854
[TBL] [Abstract][Full Text] [Related]
3. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
[TBL] [Abstract][Full Text] [Related]
5. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 53 cases of esthesioneuroblastoma].
Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
8. [The experience of treatment of 7 cases of olfactory neuroblastoma].
Zou L; Cheng Q
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Feb; 13(2):60-1. PubMed ID: 12564017
[TBL] [Abstract][Full Text] [Related]
9. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
[TBL] [Abstract][Full Text] [Related]
10. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
11. [Esthesioneuroblastoma: A single institution's experience and general literature review].
Lapierre A; Selmaji I; Samlali H; Brahmi T; Yossi S
Cancer Radiother; 2016 Dec; 20(8):783-789. PubMed ID: 27449859
[TBL] [Abstract][Full Text] [Related]
12. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy of esthesioneuroblastoma].
Strnad V; Grabenbauer GG; Dunst J; Sauer R
Strahlenther Onkol; 1994 Feb; 170(2):79-84. PubMed ID: 8108785
[TBL] [Abstract][Full Text] [Related]
14. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience.
Polin RS; Sheehan JP; Chenelle AG; Munoz E; Larner J; Phillips CD; Cantrell RW; Laws ER; Newman SA; Levine PA; Jane JA
Neurosurgery; 1998 May; 42(5):1029-37. PubMed ID: 9588547
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
16. Esthesioneuroblastoma: continued follow-up of a single institution's experience.
Loy AH; Reibel JF; Read PW; Thomas CY; Newman SA; Jane JA; Levine PA
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):134-8. PubMed ID: 16490869
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
[TBL] [Abstract][Full Text] [Related]
18. Retained role of surgery for olfactory neuroblastoma.
Smee RI; Broadley K; Williams JR; Meagher NS; Bridger GP
Head Neck; 2011 Oct; 33(10):1486-92. PubMed ID: 21928422
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy of esthesioneuroblastoma.
Eich HT; Staar S; Micke O; Eich PD; Stützer H; Müller R
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):155-60. PubMed ID: 11163509
[TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
